Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
VentureHealth
investment firm
About
VentureHealth is an investment portal for accredited investors who want access to high growth opportunities in the healthcare sector.
- San Jose,California,United States
- http://www.venturehealth.com
Highlights
Details
- Industries
- Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 2012
- Operating Status
- Active
- Investor Type
- MVC,Venture Capital
VentureHealth is an investment portal for accredited investors who want access to high growth opportunities in the $2.5 trillion healthcare sector.Our mission is to dramatically transform clinical outcomes by capitalizing breakthrough innovations.
Investments
Number of Investments
Number of Lead Investments
3
0
VentureHealth has made 3 investments. Their most recent investment was on
May 26, 2015, when Rani Therapeutics raised $37.10M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 26, 2015
Rani Therapeutics
|
Series C | $37.10M | Biotechnology | — |
|
Jul 28, 2013
Rani Therapeutics
|
Series B | $9.40M | Biotechnology | — |
|
May 2, 2013
Channel Medsystems
|
Series B | $9.78M | Biotechnology | — |
Employee Profiles
Number of Employee Profiles
2
VentureHealth has 2 current employee profiles, including
Employee Mir Imran
Employee
Executive
Exits
VentureHealth has had 1 exits. VentureHealth most notable exits include Rani Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jul 30, 2021 | Rani Therapeutics | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
